Mometasone Research Mometasone RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy and safety of GSP301 nasal spray in children aged 6-11 with seasonal allergic rhinitis
CONCLUSION: GSP301 was well tolerated and efficacious for treating SAR symptoms in pediatric subjects and demonstrated a favorable safety profile.CLINICAL TRIAL REGISTRATION: NCT03463031.PMID:35926824 | DOI:10.1016/j.anai.2022.07.029 (Source: Annals of Allergy, Asthma and Immunology)
Source: Annals of Allergy, Asthma and Immunology - August 4, 2022 Category: Allergy & Immunology Authors: Bruce M Prenner Niran J Amar Frank C Hampel Cynthia F Caracta Wen Wu Source Type: research